Colleen L. Forster

7.0k total citations · 2 hit papers
56 papers, 4.3k citations indexed

About

Colleen L. Forster is a scholar working on Molecular Biology, Physiology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Colleen L. Forster has authored 56 papers receiving a total of 4.3k indexed citations (citations by other indexed papers that have themselves been cited), including 24 papers in Molecular Biology, 14 papers in Physiology and 13 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Colleen L. Forster's work include Alzheimer's disease research and treatments (12 papers), Neuroinflammation and Neurodegeneration Mechanisms (5 papers) and Immunotherapy and Immune Responses (5 papers). Colleen L. Forster is often cited by papers focused on Alzheimer's disease research and treatments (12 papers), Neuroinflammation and Neurodegeneration Mechanisms (5 papers) and Immunotherapy and Immune Responses (5 papers). Colleen L. Forster collaborates with scholars based in United States, Canada and Sweden. Colleen L. Forster's co-authors include Karen H. Ashe, Costantino Iadecola, Karen S. SantaCruz, Linda Kotilinek, Jennifer Paulson, Eileen McGowan, Jada Lewis, Mei Yue, Michael A. Kuskowski and Martin Ingelsson and has published in prestigious journals such as Science, Proceedings of the National Academy of Sciences and Nature Communications.

In The Last Decade

Colleen L. Forster

54 papers receiving 4.3k citations

Hit Papers

Tau Suppression in a Neurodegenerative Mouse Model Improv... 2005 2026 2012 2019 2005 2005 500 1000 1.5k

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Colleen L. Forster United States 27 2.3k 1.5k 1.1k 1.0k 633 56 4.3k
Francesca Brett Ireland 21 2.7k 1.2× 1.6k 1.1× 1.1k 1.0× 1.0k 1.0× 655 1.0× 102 4.8k
Alain Buisson France 41 1.6k 0.7× 1.8k 1.2× 2.0k 1.8× 1.3k 1.3× 340 0.5× 79 5.2k
Xin Yu China 25 3.0k 1.3× 2.1k 1.4× 1.3k 1.1× 759 0.8× 816 1.3× 74 5.1k
David E. Kang United States 35 3.0k 1.3× 2.3k 1.6× 1.2k 1.0× 684 0.7× 856 1.4× 75 5.3k
Gundars Goldsteins Finland 34 1.3k 0.6× 1.5k 1.0× 1.1k 1.0× 1.8k 1.8× 366 0.6× 50 4.6k
Elena Alberdi Spain 38 1.0k 0.4× 1.6k 1.1× 1.4k 1.2× 1.3k 1.3× 353 0.6× 71 4.6k
Christine M. Hulette United States 38 3.0k 1.3× 2.3k 1.6× 946 0.8× 1.0k 1.0× 410 0.6× 84 5.7k
Hyang‐Sook Hoe South Korea 32 1.4k 0.6× 1.5k 1.0× 832 0.7× 620 0.6× 294 0.5× 92 3.3k
Elena Marcello Italy 32 1.5k 0.6× 1.3k 0.8× 1.1k 1.0× 722 0.7× 431 0.7× 72 3.4k
Claudia Schwab Canada 30 1.6k 0.7× 1.3k 0.9× 928 0.8× 1.3k 1.2× 339 0.5× 52 4.2k

Countries citing papers authored by Colleen L. Forster

Since Specialization
Citations

This map shows the geographic impact of Colleen L. Forster's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Colleen L. Forster with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Colleen L. Forster more than expected).

Fields of papers citing papers by Colleen L. Forster

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Colleen L. Forster. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Colleen L. Forster. The network helps show where Colleen L. Forster may publish in the future.

Co-authorship network of co-authors of Colleen L. Forster

This figure shows the co-authorship network connecting the top 25 collaborators of Colleen L. Forster. A scholar is included among the top collaborators of Colleen L. Forster based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Colleen L. Forster. Colleen L. Forster is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Yang, Jianbo, Matt A. Price, Colleen L. Forster, et al.. (2024). Chondroitin sulfate proteoglycan 4 increases invasion of recessive dystrophic epidermolysis bullosa-associated cutaneous squamous cell carcinoma by modifying transforming growth factor-β signalling. British Journal of Dermatology. 192(1). 104–117. 1 indexed citations
2.
Koo, Karen, Aaron Rendahl, Kyu Young Song, et al.. (2023). Expression and Prognostic Evaluation of the Receptor Tyrosine Kinase MET in Canine Malignant Melanoma. Veterinary Sciences. 10(4). 249–249.
3.
Forster, Colleen L., Carolina Sandoval-Garcia, Daniel Guillaume, et al.. (2023). MYO5A::FGFR1represents a novel fusion event in pediatric low-grade glioma. Neuro-Oncology Advances. 5(1). vdad017–vdad017. 1 indexed citations
5.
Wang, Xiaohong, Aaron L. Sarver, Christopher L. Seiler, et al.. (2022). UHRF2 regulates cell cycle, epigenetics and gene expression to control the timing of retinal progenitor and ganglion cell differentiation. Development. 149(6). 10 indexed citations
6.
Kim, Jong Hyuk, Kate Megquier, Rachael Thomas, et al.. (2021). Genomically Complex Human Angiosarcoma and Canine Hemangiosarcoma Establish Convergent Angiogenic Transcriptional Programs Driven by Novel Gene Fusions. Molecular Cancer Research. 19(5). 847–861. 16 indexed citations
7.
Herrera, Jeremy, Colleen L. Forster, Thomas Pengo, et al.. (2019). Registration of the extracellular matrix components constituting the fibroblastic focus in idiopathic pulmonary fibrosis. JCI Insight. 4(1). 61 indexed citations
8.
Benzow, Kellie, Colleen L. Forster, Lisa J. Kemper, et al.. (2019). Factors other than hTau overexpression that contribute to tauopathy-like phenotype in rTg4510 mice. Nature Communications. 10(1). 2479–2479. 118 indexed citations
9.
Amin, Khalid, Usman Yaqoob, Byron P. Vaughn, et al.. (2018). Amphiregulin in intestinal acute graft-versus-host disease: a possible diagnostic and prognostic aid. Modern Pathology. 32(4). 560–567. 12 indexed citations
10.
Herrera, Jeremy, Daniel Beisang, Mark S. Peterson, et al.. (2018). Dicer1 Deficiency in the Idiopathic Pulmonary Fibrosis Fibroblastic Focus Promotes Fibrosis by Suppressing MicroRNA Biogenesis. American Journal of Respiratory and Critical Care Medicine. 198(4). 486–496. 37 indexed citations
11.
Borgatti, Antonella, Joseph S. Koopmeiners, Aaron L. Sarver, et al.. (2017). Safe and Effective Sarcoma Therapy through Bispecific Targeting of EGFR and uPAR. Molecular Cancer Therapeutics. 16(5). 956–965. 33 indexed citations
12.
Sherman, Mathew A., Fatou Amar, Megan Larson, et al.. (2016). Soluble Conformers of Aβ and Tau Alter Selective Proteins Governing Axonal Transport. Journal of Neuroscience. 36(37). 9647–9658. 43 indexed citations
13.
Lu, Huarui, Hongbo Wang, Xiaohong Wang, et al.. (2016). Loss of UHRF2 expression is associated with human neoplasia, promoter hypermethylation, decreased 5-hydroxymethylcytosine, and high proliferative activity. Oncotarget. 7(46). 76047–76061. 18 indexed citations
14.
Lu, Huarui, et al.. (2015). Rb1 and Pten Co-Deletion in Osteoblast Precursor Cells Causes Rapid Lipoma Formation in Mice. PLoS ONE. 10(8). e0136729–e0136729. 14 indexed citations
15.
Watson, Adrienne L., Eric P. Rahrmann, Branden S. Moriarity, et al.. (2013). Canonical Wnt/β-catenin Signaling Drives Human Schwann Cell Transformation, Progression, and Tumor Maintenance. Cancer Discovery. 3(6). 674–689. 76 indexed citations
16.
Wiesner, Stephen M., Stacy A. Decker, Jon D. Larson, et al.. (2009). De novo Induction of Genetically Engineered Brain Tumors in Mice Using Plasmid DNA. Cancer Research. 69(2). 431–439. 119 indexed citations
17.
Ramsden, Martin, Linda Kotilinek, Colleen L. Forster, et al.. (2005). Age-Dependent Neurofibrillary Tangle Formation, Neuron Loss, and Memory Impairment in a Mouse Model of Human Tauopathy (P301L). Journal of Neuroscience. 25(46). 10637–10647. 529 indexed citations breakdown →
18.
SantaCruz, Karen S., Jada Lewis, Tara L. Spires‐Jones, et al.. (2005). Tau Suppression in a Neurodegenerative Mouse Model Improves Memory Function. Science. 309(5733). 476–481. 1537 indexed citations breakdown →
19.
Forster, Colleen L., Koreaki Sugimoto, H. Brent Clark, et al.. (2002). Interferon regulatory factor-1 immunoreactivity in neurons and inflammatory cells following ischemic stroke in rodents and humans. Acta Neuropathologica. 105(5). 420–424. 26 indexed citations
20.
Iadecola, Costantino, Colleen L. Forster, Shigeru Nogawa, H. Brent Clark, & M. Elizabeth Ross. (1999). Cyclooxygenase-2 immunoreactivity in the human brain following cerebral ischemia. Acta Neuropathologica. 98(1). 9–14. 139 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026